Extraordinary Researcher

Arul Chinnaiyan

TALENT ATTRACTION & RETENTION

Position: S. P. Hicks Endowed Professor of Pathology and Urology
Institution: University of Michigan Medical School
Home State: Illinois
Research Focus:
Precision therapeutics for cancer based on genetics
Impact: Innovation & Entrepreneurship
Attended:
 University of Michigan

 

“One of the reasons I stayed at the University of Michigan has been the progressive nature of the Technology Transfer Office here and the entrepreneurial opportunities that the university has provided me.”

Dr. Arul M. Chinnaiyan, M.D., Ph.D.is an investigator, an inventor and a researcher; raised in Illinois, he’s been at the University of Michigan since he was an undergrad and throughout his career.

An Investigator of the Howard Hughes Medical Institute, American Cancer Society Research Professor and S.P. Hicks Endowed Professor of Pathology and Urology at the University of Michigan, Chinnaiyan’s research has led to 18 issued patents and more than 30 pending U.S. patent applications stemming from more than 75 new inventions. These technologies have been licensed to startup companies he co-founded including OncoFusion Therapeutics, Compendia Bioscience (now part of Thermo Fisher) and Armune Bioscience, and existing companies Hologic and GenomeDx.

 

“One of the ways to really have impact on society and to generate products that will have an impact on others is to commercialize your technology.”

The Chinnaiyan laboratory is a fertile training ground for the next generation of translational researchers and has already impacted the careers of more than 20 graduate students and 50 research fellows. According to Dr. Chinnaiyan, “The long-term goal or the aspiration of my laboratory at the University of Michigan, as well as the entrepreneurial activities that I’ve been involved in, is basically to understand an individual’s cancer in a comprehensive way and tailor drug therapy based on that.”